img

Global Antibiotics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antibiotics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Antibiotic also called an antibacterial, is a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics.
The global Antibiotics market size was US$ 43180 million in 2022 and is forecast to a readjusted size of US$ 54400 million by 2034 with a CAGR of 3.3% during the forecast period 2024-2034.
More than 15.0% of the deaths, in children below the age of five, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the highest prevalence of the disease is identified to be in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one third of the infected population, thereby increasing the disease burden.
In terms of sales (consumption) side, this report focuses on the sales of Antibiotics by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Antibiotics market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Antibiotics market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Pfizer
Janssen Pharmaceuticals
Abbott
GlaxoSmithKline
Sanofi
Novartis
Bayer
Bristol Myers Squibb Company
Eli Lilly and Company
Astellas Pharma
By Type
Cephalosporins
Penicillins
Fluoroquinolones
Macrolides
Carbapenems
Aminoglycosides
Sulfonamides
Others
By Application
Hospital
Clinics
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Antibiotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibiotics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Antibiotics Definition
1.2 Market by Type
1.2.1 Global Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Cephalosporins
1.2.3 Penicillins
1.2.4 Fluoroquinolones
1.2.5 Macrolides
1.2.6 Carbapenems
1.2.7 Aminoglycosides
1.2.8 Sulfonamides
1.2.9 Others
1.3 Market Segment by Application
1.3.1 Global Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Antibiotics Sales
2.1 Global Antibiotics Revenue Estimates and Forecasts 2018-2034
2.2 Global Antibiotics Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Antibiotics Revenue by Region
2.3.1 Global Antibiotics Revenue by Region (2018-2024)
2.3.2 Global Antibiotics Revenue by Region (2024-2034)
2.4 Global Antibiotics Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Antibiotics Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Antibiotics Sales Quantity by Region
2.6.1 Global Antibiotics Sales Quantity by Region (2018-2024)
2.6.2 Global Antibiotics Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Antibiotics Sales Quantity by Manufacturers
3.1.1 Global Antibiotics Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Antibiotics Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Antibiotics Sales in 2022
3.2 Global Antibiotics Revenue by Manufacturers
3.2.1 Global Antibiotics Revenue by Manufacturers (2018-2024)
3.2.2 Global Antibiotics Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antibiotics Revenue in 2022
3.3 Global Antibiotics Sales Price by Manufacturers
3.4 Global Key Players of Antibiotics, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antibiotics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antibiotics, Product Offered and Application
3.8 Global Key Manufacturers of Antibiotics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Antibiotics Sales Quantity by Type
4.1.1 Global Antibiotics Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Antibiotics Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Antibiotics Sales Quantity Market Share by Type (2018-2034)
4.2 Global Antibiotics Revenue by Type
4.2.1 Global Antibiotics Historical Revenue by Type (2018-2024)
4.2.2 Global Antibiotics Forecasted Revenue by Type (2024-2034)
4.2.3 Global Antibiotics Revenue Market Share by Type (2018-2034)
4.3 Global Antibiotics Price by Type
4.3.1 Global Antibiotics Price by Type (2018-2024)
4.3.2 Global Antibiotics Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Antibiotics Sales Quantity by Application
5.1.1 Global Antibiotics Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Antibiotics Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Antibiotics Sales Quantity Market Share by Application (2018-2034)
5.2 Global Antibiotics Revenue by Application
5.2.1 Global Antibiotics Historical Revenue by Application (2018-2024)
5.2.2 Global Antibiotics Forecasted Revenue by Application (2024-2034)
5.2.3 Global Antibiotics Revenue Market Share by Application (2018-2034)
5.3 Global Antibiotics Price by Application
5.3.1 Global Antibiotics Price by Application (2018-2024)
5.3.2 Global Antibiotics Price Forecast by Application (2024-2034)
6 North America
6.1 North America Antibiotics Sales by Company
6.1.1 North America Antibiotics Revenue by Company (2018-2024)
6.1.2 North America Antibiotics Sales Quantity by Company (2018-2024)
6.2 North America Antibiotics Market Size by Type
6.2.1 North America Antibiotics Sales Quantity by Type (2018-2034)
6.2.2 North America Antibiotics Revenue by Type (2018-2034)
6.3 North America Antibiotics Market Size by Application
6.3.1 North America Antibiotics Sales Quantity by Application (2018-2034)
6.3.2 North America Antibiotics Revenue by Application (2018-2034)
6.4 North America Antibiotics Market Size by Country
6.4.1 North America Antibiotics Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Antibiotics Revenue by Country (2018-2034)
6.4.3 North America Antibiotics Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Antibiotics Sales by Company
7.1.1 Europe Antibiotics Sales Quantity by Company (2018-2024)
7.1.2 Europe Antibiotics Revenue by Company (2018-2024)
7.2 Europe Antibiotics Market Size by Type
7.2.1 Europe Antibiotics Sales Quantity by Type (2018-2034)
7.2.2 Europe Antibiotics Revenue by Type (2018-2034)
7.3 Europe Antibiotics Market Size by Application
7.3.1 Europe Antibiotics Sales Quantity by Application (2018-2034)
7.3.2 Europe Antibiotics Revenue by Application (2018-2034)
7.4 Europe Antibiotics Market Size by Country
7.4.1 Europe Antibiotics Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Antibiotics Revenue by Country (2018-2034)
7.4.3 Europe Antibiotics Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Antibiotics Sales by Company
8.1.1 China Antibiotics Sales Quantity by Company (2018-2024)
8.1.2 China Antibiotics Revenue by Company (2018-2024)
8.2 China Antibiotics Market Size by Type
8.2.1 China Antibiotics Sales Quantity by Type (2018-2034)
8.2.2 China Antibiotics Revenue by Type (2018-2034)
8.3 China Antibiotics Market Size by Application
8.3.1 China Antibiotics Sales Quantity by Application (2018-2034)
8.3.2 China Antibiotics Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Antibiotics Sales by Company
9.1.1 APAC Antibiotics Sales Quantity by Company (2018-2024)
9.1.2 APAC Antibiotics Revenue by Company (2018-2024)
9.2 APAC Antibiotics Market Size by Type
9.2.1 APAC Antibiotics Sales Quantity by Type (2018-2034)
9.2.2 APAC Antibiotics Revenue by Type (2018-2034)
9.3 APAC Antibiotics Market Size by Application
9.3.1 APAC Antibiotics Sales Quantity by Application (2018-2034)
9.3.2 APAC Antibiotics Revenue by Application (2018-2034)
9.4 APAC Antibiotics Market Size by Region
9.4.1 APAC Antibiotics Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Antibiotics Revenue by Region (2018-2034)
9.4.3 APAC Antibiotics Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antibiotics Sales by Company
10.1.1 Middle East, Africa and Latin America Antibiotics Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Antibiotics Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Antibiotics Market Size by Type
10.2.1 Middle East, Africa and Latin America Antibiotics Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Antibiotics Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Antibiotics Market Size by Application
10.3.1 Middle East, Africa and Latin America Antibiotics Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Antibiotics Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Antibiotics Market Size by Country
10.4.1 Middle East, Africa and Latin America Antibiotics Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Antibiotics Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Antibiotics Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Pfizer Antibiotics Products and Services
11.1.5 Pfizer Antibiotics SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Company Information
11.2.2 Janssen Pharmaceuticals Overview
11.2.3 Janssen Pharmaceuticals Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Janssen Pharmaceuticals Antibiotics Products and Services
11.2.5 Janssen Pharmaceuticals Antibiotics SWOT Analysis
11.2.6 Janssen Pharmaceuticals Recent Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Overview
11.3.3 Abbott Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Abbott Antibiotics Products and Services
11.3.5 Abbott Antibiotics SWOT Analysis
11.3.6 Abbott Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 GlaxoSmithKline Antibiotics Products and Services
11.4.5 GlaxoSmithKline Antibiotics SWOT Analysis
11.4.6 GlaxoSmithKline Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Sanofi Antibiotics Products and Services
11.5.5 Sanofi Antibiotics SWOT Analysis
11.5.6 Sanofi Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Novartis Antibiotics Products and Services
11.6.5 Novartis Antibiotics SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Overview
11.7.3 Bayer Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Bayer Antibiotics Products and Services
11.7.5 Bayer Antibiotics SWOT Analysis
11.7.6 Bayer Recent Developments
11.8 Bristol Myers Squibb Company
11.8.1 Bristol Myers Squibb Company Company Information
11.8.2 Bristol Myers Squibb Company Overview
11.8.3 Bristol Myers Squibb Company Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Bristol Myers Squibb Company Antibiotics Products and Services
11.8.5 Bristol Myers Squibb Company Antibiotics SWOT Analysis
11.8.6 Bristol Myers Squibb Company Recent Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Information
11.9.2 Eli Lilly and Company Overview
11.9.3 Eli Lilly and Company Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Eli Lilly and Company Antibiotics Products and Services
11.9.5 Eli Lilly and Company Antibiotics SWOT Analysis
11.9.6 Eli Lilly and Company Recent Developments
11.10 Astellas Pharma
11.10.1 Astellas Pharma Company Information
11.10.2 Astellas Pharma Overview
11.10.3 Astellas Pharma Antibiotics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Astellas Pharma Antibiotics Products and Services
11.10.5 Astellas Pharma Antibiotics SWOT Analysis
11.10.6 Astellas Pharma Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antibiotics Value Chain Analysis
12.2 Antibiotics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibiotics Production Mode & Process
12.4 Antibiotics Sales and Marketing
12.4.1 Antibiotics Sales Channels
12.4.2 Antibiotics Distributors
12.5 Antibiotics Customers
13 Market Dynamics
13.1 Antibiotics Industry Trends
13.2 Antibiotics Market Drivers
13.3 Antibiotics Market Challenges
13.4 Antibiotics Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antibiotics Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Cephalosporins
Table 3. Major Manufacturers of Penicillins
Table 4. Major Manufacturers of Fluoroquinolones
Table 5. Major Manufacturers of Macrolides
Table 6. Major Manufacturers of Carbapenems
Table 7. Major Manufacturers of Aminoglycosides
Table 8. Major Manufacturers of Sulfonamides
Table 9. Major Manufacturers of Others
Table 10. Global Antibiotics Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Antibiotics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 12. Global Antibiotics Revenue by Region (2018-2024) & (US$ Million)
Table 13. Global Antibiotics Revenue Market Share by Region (2018-2024)
Table 14. Global Antibiotics Revenue by Region (2024-2034) & (US$ Million)
Table 15. Global Antibiotics Revenue Market Share by Region (2024-2034)
Table 16. Global Antibiotics Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 17. Global Antibiotics Sales by Region (2018-2024) & (K Units)
Table 18. Global Antibiotics Sales Market Share by Region (2018-2024)
Table 19. Global Antibiotics Sales by Region (2024-2034) & (K Units)
Table 20. Global Antibiotics Sales Market Share by Region (2024-2034)
Table 21. Global Antibiotics Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 22. Global Antibiotics Sales Quantity Share by Manufacturers (2018-2024)
Table 23. Global Antibiotics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 24. Global Antibiotics Revenue Share by Manufacturers (2018-2024)
Table 25. Global Antibiotics Price by Manufacturers 2018-2024 (USD/Unit)
Table 26. Global Key Players of Antibiotics, Industry Ranking, 2021 VS 2022
Table 27. Global Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotics as of 2022)
Table 29. Global Key Manufacturers of Antibiotics, Manufacturing Base Distribution and Headquarters
Table 30. Global Key Manufacturers of Antibiotics, Product Offered and Application
Table 31. Global Key Manufacturers of Antibiotics, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Antibiotics Sales Quantity by Type (2018-2024) & (K Units)
Table 34. Global Antibiotics Sales Quantity by Type (2024-2034) & (K Units)
Table 35. Global Antibiotics Sales Quantity Share by Type (2018-2024)
Table 36. Global Antibiotics Sales Quantity Share by Type (2024-2034)
Table 37. Global Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 38. Global Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 39. Global Antibiotics Revenue Share by Type (2018-2024)
Table 40. Global Antibiotics Revenue Share by Type (2024-2034)
Table 41. Antibiotics Price by Type (2018-2024) & (USD/Unit)
Table 42. Global Antibiotics Price Forecast by Type (2024-2034) & (USD/Unit)
Table 43. Global Antibiotics Sales Quantity by Application (2018-2024) & (K Units)
Table 44. Global Antibiotics Sales Quantity by Application (2024-2034) & (K Units)
Table 45. Global Antibiotics Sales Quantity Share by Application (2018-2024)
Table 46. Global Antibiotics Sales Quantity Share by Application (2024-2034)
Table 47. Global Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 48. Global Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 49. Global Antibiotics Revenue Share by Application (2018-2024)
Table 50. Global Antibiotics Revenue Share by Application (2024-2034)
Table 51. Antibiotics Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Antibiotics Price Forecast by Application (2024-2034) & (USD/Unit)
Table 53. North America Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 54. North America Antibiotics Sales Quantity by Company (2018-2024) & (K Units)
Table 55. North America Antibiotics Sales Quantity by Type (2018-2024) & (K Units)
Table 56. North America Antibiotics Sales Quantity by Type (2024-2034) & (K Units)
Table 57. North America Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 58. North America Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 59. North America Antibiotics Sales Quantity by Application (2018-2024) & (K Units)
Table 60. North America Antibiotics Sales Quantity by Application (2024-2034) & (K Units)
Table 61. North America Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 62. North America Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 63. North America Antibiotics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 64. North America Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 65. North America Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 66. North America Antibiotics Sales Quantity by Country (2018-2024) & (K Units)
Table 67. North America Antibiotics Sales Quantity by Country (2024-2034) & (K Units)
Table 68. Europe Antibiotics Sales Quantity by Company (2018-2024) & (K Units)
Table 69. Europe Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 70. Europe Antibiotics Sales Quantity by Type (2018-2024) & (K Units)
Table 71. Europe Antibiotics Sales Quantity by Type (2024-2034) & (K Units)
Table 72. Europe Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 73. Europe Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 74. Europe Antibiotics Sales Quantity by Application (2018-2024) & (K Units)
Table 75. Europe Antibiotics Sales Quantity by Application (2024-2034) & (K Units)
Table 76. Europe Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 77. Europe Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 78. Europe Antibiotics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 79. Europe Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 80. Europe Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 81. Europe Antibiotics Sales Quantity by Country (2018-2024) & (K Units)
Table 82. Europe Antibiotics Sales Quantity by Country (2024-2034) & (K Units)
Table 83. China Antibiotics Sales Quantity by Company (2018-2024) & (K Units)
Table 84. China Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 85. China Antibiotics Sales Quantity by Type (2018-2024) & (K Units)
Table 86. China Antibiotics Sales Quantity by Type (2024-2034) & (K Units)
Table 87. China Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 88. China Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 89. China Antibiotics Sales Quantity by Application (2018-2024) & (K Units)
Table 90. China Antibiotics Sales Quantity by Application (2024-2034) & (K Units)
Table 91. China Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 92. China Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 93. APAC Antibiotics Sales Quantity by Company (2018-2024) & (K Units)
Table 94. APAC Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 95. APAC Antibiotics Sales Quantity by Type (2018-2024) & (K Units)
Table 96. APAC Antibiotics Sales Quantity by Type (2024-2034) & (K Units)
Table 97. APAC Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 98. APAC Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 99. APAC Antibiotics Sales Quantity by Application (2018-2024) & (K Units)
Table 100. APAC Antibiotics Sales Quantity by Application (2024-2034) & (K Units)
Table 101. APAC Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 102. APAC Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 103. APAC Antibiotics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 104. APAC Antibiotics Revenue by Region (2018-2024) & (US$ Million)
Table 105. APAC Antibiotics Revenue by Region (2024-2034) & (US$ Million)
Table 106. APAC Antibiotics Sales Quantity by Region (2018-2024) & (K Units)
Table 107. APAC Antibiotics Sales Quantity by Region (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Antibiotics Sales Quantity by Company (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Antibiotics Sales Quantity by Type (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Antibiotics Sales Quantity by Type (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Antibiotics Revenue by Type (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Antibiotics Revenue by Type (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Antibiotics Sales Quantity by Application (2018-2024) & (K Units)
Table 115. Middle East, Africa and Latin America Antibiotics Sales Quantity by Application (2024-2034) & (K Units)
Table 116. Middle East, Africa and Latin America Antibiotics Revenue by Application (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Antibiotics Revenue by Application (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Antibiotics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 119. Middle East, Africa and Latin America Antibiotics Revenue by Country (2018-2024) & (US$ Million)
Table 120. Middle East, Africa and Latin America Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 121. Middle East, Africa and Latin America Antibiotics Sales Quantity by Country (2018-2024) & (K Units)
Table 122. Middle East, Africa and Latin America Antibiotics Sales Quantity by Country (2024-2034) & (K Units)
Table 123. Pfizer Company Information
Table 124. Pfizer Description and Overview
Table 125. Pfizer Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Pfizer Antibiotics Product and Services
Table 127. Pfizer Antibiotics SWOT Analysis
Table 128. Pfizer Recent Developments
Table 129. Janssen Pharmaceuticals Company Information
Table 130. Janssen Pharmaceuticals Description and Overview
Table 131. Janssen Pharmaceuticals Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Janssen Pharmaceuticals Antibiotics Product and Services
Table 133. Janssen Pharmaceuticals Antibiotics SWOT Analysis
Table 134. Janssen Pharmaceuticals Recent Developments
Table 135. Abbott Company Information
Table 136. Abbott Description and Overview
Table 137. Abbott Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Abbott Antibiotics Product and Services
Table 139. Abbott Antibiotics SWOT Analysis
Table 140. Abbott Recent Developments
Table 141. GlaxoSmithKline Company Information
Table 142. GlaxoSmithKline Description and Overview
Table 143. GlaxoSmithKline Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. GlaxoSmithKline Antibiotics Product and Services
Table 145. GlaxoSmithKline Antibiotics SWOT Analysis
Table 146. GlaxoSmithKline Recent Developments
Table 147. Sanofi Company Information
Table 148. Sanofi Description and Overview
Table 149. Sanofi Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. Sanofi Antibiotics Product and Services
Table 151. Sanofi Antibiotics SWOT Analysis
Table 152. Sanofi Recent Developments
Table 153. Novartis Company Information
Table 154. Novartis Description and Overview
Table 155. Novartis Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. Novartis Antibiotics Product and Services
Table 157. Novartis Antibiotics SWOT Analysis
Table 158. Novartis Recent Developments
Table 159. Bayer Company Information
Table 160. Bayer Description and Overview
Table 161. Bayer Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 162. Bayer Antibiotics Product and Services
Table 163. Bayer Antibiotics SWOT Analysis
Table 164. Bayer Recent Developments
Table 165. Bristol Myers Squibb Company Company Information
Table 166. Bristol Myers Squibb Company Description and Overview
Table 167. Bristol Myers Squibb Company Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 168. Bristol Myers Squibb Company Antibiotics Product and Services
Table 169. Bristol Myers Squibb Company Antibiotics SWOT Analysis
Table 170. Bristol Myers Squibb Company Recent Developments
Table 171. Eli Lilly and Company Company Information
Table 172. Eli Lilly and Company Description and Overview
Table 173. Eli Lilly and Company Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 174. Eli Lilly and Company Antibiotics Product and Services
Table 175. Eli Lilly and Company Antibiotics SWOT Analysis
Table 176. Eli Lilly and Company Recent Developments
Table 177. Astellas Pharma Company Information
Table 178. Astellas Pharma Description and Overview
Table 179. Astellas Pharma Antibiotics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 180. Astellas Pharma Antibiotics Product and Services
Table 181. Astellas Pharma Antibiotics SWOT Analysis
Table 182. Astellas Pharma Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Antibiotics Distributors List
Table 186. Antibiotics Customers List
Table 187. Antibiotics Market Trends
Table 188. Antibiotics Market Drivers
Table 189. Antibiotics Market Challenges
Table 190. Antibiotics Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibiotics Product Picture
Figure 2. Global Antibiotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antibiotics Market Share by Type in 2022 & 2034
Figure 4. Cephalosporins Product Picture
Figure 5. Penicillins Product Picture
Figure 6. Fluoroquinolones Product Picture
Figure 7. Macrolides Product Picture
Figure 8. Carbapenems Product Picture
Figure 9. Aminoglycosides Product Picture
Figure 10. Sulfonamides Product Picture
Figure 11. Others Product Picture
Figure 12. Global Antibiotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 13. Global Antibiotics Market Share by Application in 2022 & 2034
Figure 14. Hospital
Figure 15. Clinics
Figure 16. Others
Figure 17. Antibiotics Report Years Considered
Figure 18. Global Antibiotics Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 19. Global Antibiotics Revenue 2018-2034 (US$ Million)
Figure 20. Global Antibiotics Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 21. Global Antibiotics Sales Quantity 2018-2034 (K Units)
Figure 22. Global Antibiotics Sales Quantity Market Share by Region (2018-2024)
Figure 23. Global Antibiotics Sales Quantity Market Share by Region (2024-2034)
Figure 24. North America Antibiotics Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. North America Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Europe Antibiotics Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Europe Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 28. China Antibiotics Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. China Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 30. APAC Antibiotics Sales Quantity YoY (2018-2034) & (K Units)
Figure 31. APAC Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Antibiotics Sales Quantity YoY (2018-2034) & (K Units)
Figure 33. Middle East, Africa and Latin America Antibiotics Revenue YoY (2018-2034) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Antibiotics Sales Quantity in 2022
Figure 35. The Top 10 and Top 5 Players Market Share by Antibiotics Revenue in 2022
Figure 36. Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 38. Global Antibiotics Revenue Market Share by Type (2018-2034)
Figure 39. Global Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 40. Global Antibiotics Revenue Market Share by Application (2018-2034)
Figure 41. North America Antibiotics Revenue Market Share by Company in 2022
Figure 42. North America Antibiotics Sales Quantity Market Share by Company in 2022
Figure 43. North America Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 44. North America Antibiotics Revenue Market Share by Type (2018-2034)
Figure 45. North America Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 46. North America Antibiotics Revenue Market Share by Application (2018-2034)
Figure 47. North America Antibiotics Revenue Share by Country (2018-2034)
Figure 48. North America Antibiotics Sales Quantity Share by Country (2018-2034)
Figure 49. U.S. Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 50. Canada Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 51. Europe Antibiotics Sales Quantity Market Share by Company in 2022
Figure 52. Europe Antibiotics Revenue Market Share by Company in 2022
Figure 53. Europe Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 54. Europe Antibiotics Revenue Market Share by Type (2018-2034)
Figure 55. Europe Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 56. Europe Antibiotics Revenue Market Share by Application (2018-2034)
Figure 57. Europe Antibiotics Revenue Share by Country (2018-2034)
Figure 58. Europe Antibiotics Sales Quantity Share by Country (2018-2034)
Figure 59. Germany Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 60. France Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 61. U.K. Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 62. Italy Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 63. Russia Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 64. China Antibiotics Sales Quantity Market Share by Company in 2022
Figure 65. China Antibiotics Revenue Market Share by Company in 2022
Figure 66. China Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 67. China Antibiotics Revenue Market Share by Type (2018-2034)
Figure 68. China Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 69. China Antibiotics Revenue Market Share by Application (2018-2034)
Figure 70. APAC Antibiotics Sales Quantity Market Share by Company in 2022
Figure 71. APAC Antibiotics Revenue Market Share by Company in 2022
Figure 72. APAC Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 73. APAC Antibiotics Revenue Market Share by Type (2018-2034)
Figure 74. APAC Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 75. APAC Antibiotics Revenue Market Share by Application (2018-2034)
Figure 76. APAC Antibiotics Revenue Share by Region (2018-2034)
Figure 77. APAC Antibiotics Sales Quantity Share by Region (2018-2034)
Figure 78. Japan Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 79. South Korea Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 80. China Taiwan Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 81. Southeast Asia Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 82. India Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 83. Middle East, Africa and Latin America Antibiotics Sales Quantity Market Share by Company in 2022
Figure 84. Middle East, Africa and Latin America Antibiotics Revenue Market Share by Company in 2022
Figure 85. Middle East, Africa and Latin America Antibiotics Sales Quantity Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Antibiotics Revenue Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Antibiotics Sales Quantity Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Antibiotics Revenue Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Antibiotics Sales Quantity Share by Country (2018-2034)
Figure 90. Middle East, Africa and Latin America Antibiotics Revenue Share by Country (2018-2034)
Figure 91. Brazil Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 92. Mexico Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 93. Turkey Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 94. Israel Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 95. GCC Countries Antibiotics Revenue (2018-2034) & (US$ Million)
Figure 96. Antibiotics Value Chain
Figure 97. Antibiotics Production Process
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed